Benitec Biopharma Inc. (BNTC) — Dilution Risk Analysis

Current Snapshot

Benitec Biopharma Inc. (BNTC) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
34,882,726 Source
Public Float
17,873,186 Source
Float as % of Outstanding
51.2%

Dilution Risk Score

Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: XBRL 1, 424B3 1, EFFECT 1, S-3 1, 4 1.

FormFiledAccession
xbrl 2026-06-30 xbrl-4284-xbrl_warrant
424B3 2026-02-11 0001193125-26-044984
EFFECT 2026-02-10 9999999995-26-000516
S-3 2026-01-30 0001193125-26-031753
4 2026-01-26 0001012975-26-000082

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $100,000,000 Source
ATM offering capacity remaining $100,000,000 Source
Cash runway 130 months Source
Three-year share count growth 1256.02% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 65/10) Source
Cash Runway
130 months Source
ATM Offering Capacity Remaining
$100,000,000 Source
Shelf Registration Capacity
$100,000,000 Source
Share Count Growth (3-Year)
1256.02% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.